Vanguard Portfolio Management (VIR) discloses 11.6M-share Vir Biotechnology position

Vanguard Portfolio Management has disclosed a beneficial ownership of 11,554,377 shares of Vir Biotechnology Inc. common stock, representing 6.85% of the class as of June 30, 2026. This information was reported on an amended Schedule 13G filing. Vanguard holds sole voting power over 59,162 shares and sole dispositive power over all 11,554,377 shares, on behalf of its affiliated entities and managed accounts.